Brief: Lifemd Launches Testorx, A New Rex MD Direct-To-Consumer Testosterone Replacement Therapy Telehealth Offering
23/10/2024 15:31
Oct 23 (Reuters) - LifeMD Inc LFMD.O :
* LIFEMD® LAUNCHES TESTORX, A NEW REX MD® DIRECT-TO-CONSUMER
TESTOSTERONE REPLACEMENT THERAPY TELEHEALTH OFFERING
Source text for Eikon: ID:nGNX7kVGtT
Further company coverage: LFMD.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on LifeMD
See all newsLifeMD Q1 revenue beats estimates on record telehealth subscriber additons
Brief: LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million
LifeMD rises after adding new daily obesity pill to weight management program
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US (updated)
Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US